Publicaciones en las que colabora con FRANCISCO CRUZ CORONEL DÍAZ (28)

2006

  1. Pre-transplant treatment modality and renal transplant outcomes

    Dialysis and Transplantation, Vol. 35, Núm. 8, pp. 515-518

2002

  1. Pulmonary diffusing capacity in chronic dialysis patients

    Respiratory Medicine, Vol. 96, Núm. 7, pp. 487-492

2001

  1. Calciphylaxis: an uncertain pathogenesis and controversial treatment

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21, Núm. 6, pp. 596-600

1997

  1. A prospective longitudinal study of bone densitometry in patients starting peritoneal dialysis

    Peritoneal Dialysis International, Vol. 17, Núm. 1, pp. 80-82

1996

  1. Abnormalities of Heme Biosynthesis in Experimental Acute Renal Failure

    Journal of the American Society of Nephrology, Vol. 7, Núm. 4, pp. 628-632

  2. Aspergillus infection of a renal allograft without evidence of a site of origin

    Nephrology Dialysis Transplantation, Vol. 11, Núm. 8, pp. 1639-1642

  3. Densitometria osea en pacientes tratados con dialisis peritoneal

    Nefrologia, Vol. 16, Núm. 4, pp. 342-346

  4. Double renal transplant from infant donors: A good alternative for adult recipients

    Transplantation, Vol. 61, Núm. 1, pp. 37-40

  5. Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis

    Journal of the American Society of Nephrology, Vol. 7, Núm. 5, pp. 774-779

1995

  1. Efficiency of three different hemodialysis membranes for plasma porphyrin removal

    American Journal of Kidney Diseases, Vol. 25, Núm. 1, pp. 30-33

  2. HIPERLIPIDEMIA EN EL TRASPLANTE RENAL. TRATAMIENTO CON PANTETINA

    Nefrologia, Vol. 15, Núm. 1, pp. 68-73

1993

  1. Iron deficiency anemia after successful renal transplantation

    Journal of Urology, Vol. 149, Núm. 6, pp. 1398-1400

1991

  1. Fructosamine levels in CAPD: its value as glycemic index.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 7, pp. 253-256

  2. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 7, pp. 35-38

  3. Treatment of hyperlipidemia in diabetic patients on dialysis with a physiological substance

    American Journal of Nephrology, Vol. 11, Núm. 1, pp. 32-36

1990

  1. Bone histomorphometry of the diabetic patient on CAPD: Correlation with radiology and parathormone

    Dialysis and Transplantation, Vol. 19, Núm. 8, pp. 424-425+427+433

  2. Diabetic patients on CAPD need less aluminum hydroxide as a phosphate binder than non-diabetics.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 6, pp. 50-52

  3. Partial Substitution of Sodium Lactate for Sodium Acetate in the Bath Fluid for Hemodialysis

    Artificial Organs, Vol. 14, Núm. 1, pp. 2-6